Indications |
Oral Head injury Adult: 200-600 mg daily in divided doses. Oral Cerebrovascular disorders Adult: 200-600 mg daily in divided doses. Oral Parkinsonism Adult: 200-600 mg daily in divided doses. Parenteral Head injury Adult: Up to 1 g IM/IV daily. Parenteral Cerebrovascular disorders Adult: Up to 1 g IM/IV daily. Parenteral Parkinsonism Adult: Up to 1 g IM/IV daily. |
Mechanism of Actions |
Citicoline increases blood flow and O2 consumption in the brain. It is also involved in the biosynthesis of lecithin. |
Administration |
May be taken with or without food. (Take w/ or between meals.) |
ATC Classification |
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and nootropics. |
Available As |
|
Citicoline
Post Review about Citicoline Click here to cancel reply.
Citicoline Containing Brands
Citicoline is used in following diseases
Drug - Drug Interactions of Citicoline
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.